Yangping Wu

1.6k total citations · 1 hit paper
22 papers, 933 citations indexed

About

Yangping Wu is a scholar working on Molecular Biology, Oncology and Immunology. According to data from OpenAlex, Yangping Wu has authored 22 papers receiving a total of 933 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Molecular Biology, 11 papers in Oncology and 6 papers in Immunology. Recurrent topics in Yangping Wu's work include Cancer Cells and Metastasis (3 papers), Immune cells in cancer (3 papers) and Monoclonal and Polyclonal Antibodies Research (3 papers). Yangping Wu is often cited by papers focused on Cancer Cells and Metastasis (3 papers), Immune cells in cancer (3 papers) and Monoclonal and Polyclonal Antibodies Research (3 papers). Yangping Wu collaborates with scholars based in China, United States and France. Yangping Wu's co-authors include Jinliang Yang, Xi Chen, Yuxi Wang, Qiang Chen, Yamei Yu, Qinhuai Lai, Benoı̂t Gigant, Hang Zhang, Qian Lei and Weimin Li and has published in prestigious journals such as Nature Communications, SHILAP Revista de lepidopterología and PLoS ONE.

In The Last Decade

Yangping Wu

21 papers receiving 930 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Cancer-cell stiffening via cholesterol depletion enhances adoptive T-cell immunotherapy

2021 176 citations Kewen Lei, Armand Kurum et al. Nature Biomedical Engineering profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Yangping Wu China	14	509	244	212	152	124	22	933
Salvatore Di Maro Italy	25	755 1.5×	260 1.1×	227 1.1×	76 0.5×	164 1.3×	63	1.3k
Bainan Wu United States	22	880 1.7×	244 1.0×	150 0.7×	87 0.6×	103 0.8×	28	1.2k
George Vielhauer United States	23	905 1.8×	187 0.8×	304 1.4×	90 0.6×	162 1.3×	33	1.4k
Mark Agostino Australia	16	778 1.5×	165 0.7×	153 0.7×	73 0.5×	89 0.7×	41	1.1k
Ningyu Wang China	22	918 1.8×	307 1.3×	338 1.6×	79 0.5×	113 0.9×	84	1.5k
Linda Rickardson Sweden	18	705 1.4×	290 1.2×	82 0.4×	103 0.7×	91 0.7×	28	1.1k
Chunlai Nie China	22	796 1.6×	293 1.2×	90 0.4×	66 0.4×	138 1.1×	57	1.3k
Xiujun Liu China	18	472 0.9×	268 1.1×	155 0.7×	46 0.3×	125 1.0×	61	832
Qing Wen China	19	479 0.9×	162 0.7×	179 0.8×	55 0.4×	51 0.4×	41	926

Countries citing papers authored by Yangping Wu

Since Specialization

Citations

This map shows the geographic impact of Yangping Wu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yangping Wu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yangping Wu more than expected).

Fields of papers citing papers by Yangping Wu

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yangping Wu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yangping Wu. The network helps show where Yangping Wu may publish in the future.

Co-authorship network of co-authors of Yangping Wu

This figure shows the co-authorship network connecting the top 25 collaborators of Yangping Wu. A scholar is included among the top collaborators of Yangping Wu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yangping Wu. Yangping Wu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Wu, Yangping, et al.. (2025). Research progress on mechanisms of tumor immune microenvironment and gastrointestinal resistance to immunotherapy: mini review. Frontiers in Immunology. 16. 1641518–1641518.

Li, Jianmei, Yixin Liu, Jie Dai, et al.. (2025). mRNA Vaccines: Current Applications and Future Directions. MedComm. 6(11). e70434–e70434. 1 indexed citations

Wu, Yangping, Wenting Li, Xi Chen, et al.. (2023). DOG1 as a novel antibody-drug conjugate target for the treatment of multiple gastrointestinal tumors and liver metastasis. Frontiers in Immunology. 14. 1051506–1051506. 4 indexed citations

Liu, Yixin, Xi Chen, Ying Xu, et al.. (2023). CTHRC1 promotes colorectal cancer progression by recruiting tumor-associated macrophages via up-regulation of CCL15. Journal of Molecular Medicine. 102(1). 81–94. 9 indexed citations

Lei, Kewen, Armand Kurum, Murat Kaynak, et al.. (2021). Cancer-cell stiffening via cholesterol depletion enhances adoptive T-cell immunotherapy. Nature Biomedical Engineering. 5(12). 1411–1425. 176 indexed citations breakdown →

Peng, Yujia, Jun Mou, Xiaohua Jiang, et al.. (2021). Combination Foretinib and Anti-PD-1 Antibody Immunotherapy for Colorectal Carcinoma. Frontiers in Cell and Developmental Biology. 9. 689727–689727. 29 indexed citations

Wei, Mingtian, Yaguang Zhang, Xuyang Yang, et al.. (2021). Claudin‐2 promotes colorectal cancer growth and metastasis by suppressing NDRG1 transcription. SHILAP Revista de lepidopterología. 11(12). e667–e667. 39 indexed citations

Deng, Hui, Qian Lei, Yangping Wu, Yang He, & Weimin Li. (2020). Activity-based protein profiling: Recent advances in medicinal chemistry. European Journal of Medicinal Chemistry. 191. 112151–112151. 81 indexed citations

Jiang, Yuting, Qian Lei, Yangping Wu, et al.. (2019). Potential Diagnostic and Prognostic Biomarkers of Circular RNAs for Lung Cancer in China. BioMed Research International. 2019. 1–17. 13 indexed citations

10.

Cheng, Jie, Yangping Wu, Yuxi Wang, et al.. (2017). Structure of a benzylidene derivative of 9(10H)-anthracenone in complex with tubulin provides a rationale for drug design. Biochemical and Biophysical Research Communications. 495(1). 185–188. 6 indexed citations

11.

Zhang, Hang, Yuxi Wang, Yangping Wu, et al.. (2017). Therapeutic potential of an anti-HER2 single chain antibody–DM1 conjugates for the treatment of HER2-positive cancer. Signal Transduction and Targeted Therapy. 2(1). 17015–17015. 32 indexed citations

12.

Wang, Yuxi, Yamei Yu, Guo‐Bo Li, et al.. (2017). Mechanism of microtubule stabilization by taccalonolide AJ. Nature Communications. 8(1). 15787–15787. 61 indexed citations

13.

Wei, Mingtian, Tinghan Yang, Xi Chen, et al.. (2017). Malignant ascites-derived exosomes promote proliferation and induce carcinoma-associated fibroblasts transition in peritoneal mesothelial cells. Oncotarget. 8(26). 42262–42271. 64 indexed citations

14.

Wu, Yangping, Xi Chen, Xiaojun Ge, et al.. (2015). Isoliquiritigenin prevents the progression of psoriasis-like symptoms by inhibiting NF-κB and proinflammatory cytokines. Journal of Molecular Medicine. 94(2). 195–206. 39 indexed citations

15.

Wang, Yuxi, Frederick W. Benz, Yangping Wu, et al.. (2015). Structural Insights into the Pharmacophore of Vinca Domain Inhibitors of Microtubules. Molecular Pharmacology. 89(2). 233–242. 58 indexed citations

16.

Wang, Yuxi, Hang Zhang, Benoı̂t Gigant, et al.. (2015). Structures of a diverse set of colchicine binding site inhibitors in complex with tubulin provide a rationale for drug discovery. FEBS Journal. 283(1). 102–111. 189 indexed citations

17.

Yang, Jinliang, et al.. (2014). Polymorphisms in CISH Gene Are Associated with Persistent Hepatitis B Virus Infection in Han Chinese Population. PLoS ONE. 9(6). e100826–e100826. 14 indexed citations

18.

Lin, Yu, Yuxi Wang, Yuqin Yao, et al.. (2014). Eradication of Growth of HER2-Positive Ovarian Cancer With Trastuzumab-DM1, an Antibody-Cytotoxic Drug Conjugate in Mouse Xenograft Model. International Journal of Gynecological Cancer. 24(7). 1158–1164. 27 indexed citations

19.

Yu, Tao, et al.. (2013). High interstitial fluid pressure promotes tumor progression through inducing lymphatic metastasis-related protein expressions in oral squamous cell carcinoma. Clinical & Translational Oncology. 16(6). 539–547. 13 indexed citations

20.

Chen, Xi, Yangping Wu, Yangfu Jiang, et al.. (2012). Isoliquiritigenin inhibits the growth of multiple myeloma via blocking IL-6 signaling. Journal of Molecular Medicine. 90(11). 1311–1319. 30 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact